non responders to semaglutide responder Why Some Patients Do Not Respond GLP-1 Therapies Why some people don't lose – Can Nonresponders to Antiobesity Medicines

Over one billion people globally meet the clinical definition of obesity

Semaglutide belongs to the GLP-1 receptor agonist class, which mimics a natural hormone in the body known as glucagon-like peptide-1

GLP-1 binds to the GLP-1 receptor (GLP-1R)

The GIP receptor plays an additional role in fat tissue metabolism and energy expenditure

Tran also included in exclusion criteria, History of, or known hypersensitivity to, monoclonal antibody drugs, which makes sense in Eli Lillys trial, because Bimagrumab is a monoclonal antibody

Overall prescribing trends The study found that 1,828,203 patients were prescribed a GLP-1 RA between January 2018 and December 2024, with 8,412,584 total prescriptions during this period